Homepage
Author:
ALAR PHARMACEUTICALS INC
Posted Date:
March 16, 2026
Alar Announced Buprenorphine Injectable, ALA-1000, Demonstrated Long-Term Efficacy and Favorable Safety Profile in Canine Osteoarthritis Pain Management
ALAR PHARMACEUTICALS INC
March 16, 2026